Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease - Where Do We Stand in 2025

ERN ReCONNET via YouTube

Overview

Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join a comprehensive webinar exploring the latest developments in treating systemic sclerosis-associated interstitial lung disease (SSc-ILD). Learn about evolving treatment landscapes, new drug developments, and current strategic approaches from renowned expert Prof. David Launay of Lille University Hospital. Gain insights into recommended guidelines, current knowledge, and upcoming challenges in managing this complication. Understand the patient's perspective on ILD while benefiting from the expertise of moderators Prof. Vanessa Smith and Prof. Marco Matucci Cerinic. Discover the latest research findings from Prof. Launay, a distinguished researcher with over 400 published manuscripts and president of the French Research Group on Systemic Sclerosis, as he shares his extensive knowledge in auto-immune diseases and translational research in inflammation. Explore current treatment options, understand unmet needs, and stay updated with the most recent therapeutic strategies in SSc-ILD management.

Syllabus

Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?

Taught by

ERN ReCONNET

Reviews

Start your review of Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease - Where Do We Stand in 2025

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.